Form 4: Ginkgo Bioworks Holdings Executive Receives Stock Grant
Insider Transaction (Form 4)
Jason R Kelly, See remarks and a Director of Ginkgo Bioworks Holdings, Inc., reported multiple transactions in common stock on July 28, 2026.
Summary
- Grant/award: acquired 74,258 Restricted Stock Units on July 28, 2026; holds 74,258 after (Direct).
- Grant/award: acquired 309,467 Restricted Stock Units on July 28, 2026; holds 309,467 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Jason R Kelly — Director, Officer (See remarks)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-28 | Grant/award | Restricted Stock Units | 74,258 | — | — | 74,258 |
| 2026-07-28 | Grant/award | Restricted Stock Units | 309,467 | — | — | 309,467 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-28 | Grant/award (74,258 shares) |
| 2026-07-28 | Grant/award (309,467 shares) |
Keywords
insider transaction, Form 4, DNA, Ginkgo Bioworks Holdings, Inc., neutral, Jason R Kelly
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.